Showing results (1751-1760 of 16,597) with videos related to
Sort By:
Pageof 1,660
Cancer Letters|February 13, 2017
Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biologyHan-Xiang Zhan, Bin Zhou, Yu-Gang Cheng, et al.Cancer Letters|January 21, 2017
MHC class II restricted neoantigen: A promising target in tumor immunotherapyZhichen Sun, Fangjun Chen, Fanyan Meng, et al.Cancer Letters|March 26, 2019
Reactive oxygen species and cancer: A complex interactionSankaralingam Saikolappan, Binod Kumar, Gauri Shishodia, et al.Cancer Letters|March 26, 2019
Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancerTao Wei, Xiaoyu Zhang, Qi Zhang, et al.Cancer Letters|March 26, 2019
Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machineryFrancisco Exposito, Maria Villalba, Miriam Redrado, et al.Cancer Letters|March 26, 2019
Metabolic reprogramming of macrophages during infections and cancerShiyao Wang, Ruichen Liu, Qing Yu, et al.Cancer Letters|March 27, 2019
Epigenetic regulation of UDP-Glucuronosyltransferase by microRNA-200a/-183: implications for responses to sorafenib treatment in patients with hepatocellular carcinomaYang Ge, Shuzhen Chen, Wei Mu, et al.Cancer Letters|March 25, 2019
Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesionYouyi Chen, I Wayan Sumardika, Nahoko Tomonobu, et al.Cancer Letters|March 25, 2019
Metabolomics of neonatal blood spots reveal distinct phenotypes of pediatric acute lymphoblastic leukemia and potential effects of early-life nutritionLauren M Petrick, Courtney Schiffman, William M B Edmands, et al.Cancer Letters|April 7, 2019
Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITDAnna J Dellomo, Maria R Baer, Feyruz V RassoolPageof 1,660